Bulk drug as a stepping stone for further industrial leap.

Published: 2003-04-21 06:56:00

Updated: 2003-04-21 06:56:00

The Korea New Drug R&D Association (hereinafter called Association) discussed in depth with Director Chang Joon-shik of the KFDA Drug Safety Bureau over the subject of the government support for the bulk drugs and its export strategy, and announced that the Association would take part in the sele...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK